The acceptability of isoflavones as a treatment of menopausal symptoms: a European survey among postmenopausal women
Koebnick, C., Reimann, M., Hallund, J., Rossi, L., Branca, F., Hall, W., Williams, C., Zunft, H.J.F., Jensen, K.O.D. , Carlsohn, A., Korzen-Bohr, S. and Bugel, S. (2005) The acceptability of isoflavones as a treatment of menopausal symptoms: a European survey among postmenopausal women. Climacteric, 8 (3). pp. 230-242. ISSN 1369-7137
Full text not archived in this repository.
To link to this article DOI: 10.1080/13697130500118092
Objective: To investigate determinants of the acceptability of isoflavone products among postmenopausal women with regard to social and lifestyle factors, dietary habits, health concerns, food beliefs, menopausal symptoms and therapies, and to elucidate preferences for specific products. Methods: A consumer survey was conducted among postmenopausal women in four European countries (Germany, Denmark, Italy and the UK), including a total of 465 respondents. Results: The declared acceptability of isoflavones was highest in Germany (80%), followed by Italy (75%), the UK (59%) and Denmark (55%; p < 0.001). Among other factors, prior information about isoflavones (odds ratio (OR) 2.64, 95% confidence interval (CI) 1.54-4.51, p < 0.001) and belief that foods can be used to treat medical conditions (OR 2.18, 95% CI 1.17-4.05, p=0.014) were the strongest predictors of potential acceptability. The preferred forms in which isoflavones might be taken differed markedly between countries. Conclusions: Information about the health effects of isoflavones and health-diet links should be considered the most important factors in attempts to influence the potential acceptability of isoflavone products. Foods enriched with isoflavones need to be developed with regard to specific cultural demands in order to assure consumer acceptance on the marketplace.